small molecule therapeutic for type 2 diabetes (Nanjing C & O Pharmaceutical Technology)

N/A

Report date: 2025/01/26 17:05:28
NME

Base Information

Drug Namesmall molecule therapeutic for type 2 diabetes (Nanjing C & O Pharmaceutical Technology)
Drug Alias Nameaogelieting hydrochlorideaogliptin hydrochloride
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDipeptidyl peptidase IV inhibitors
TargetsDipeptidyl peptidase IV
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Chang'Ao Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Chang'Ao Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A